Short-Term Debt to Capital: Quidel Corporation (QDEL)

The linear price action on the GURU.Markets platform chart for QuidelOrtho (QDEL), which has a debt ratio of 0.41, demonstrates the position of this diagnostics giant. The business relies on a global network of instruments, generating profit from the sale of consumables. Development is focused on device compactness and the robotization of tests. Success is driven by leading biochemists, attracted by substantial funding for scientific research and noble goals.

For the long-term investor, the reliability of QuidelOrtho (QDEL) currently depends on its ability to service obligations amid falling demand for rapid tests and rising unit costs. The ratio of loans under one year to equity, reflected in this short-term liabilities-to-equity chart, measures the risk of liquidity loss, confirming the stability of the company's financial structure during the restructuring of its operating leverage.